Zydus Animal Health Limited, a premier Animal Health Company of India, is a 100% Subsidiary of Cadila Healthcare Limited (www.zyduscadila.com).
A respected name in the Indian Animal Health Industry, Zydus Animal Health Limited has a strong presence in all the major therapeutic segments. For a particular focus and in order to cater to specific needs of different animal species, Zydus AHL operates through strategic business units (SBUs).
Zydus AHL, with a technically trained field force and an organized distribution network, provides round-the-clock technical services to the veterinary and farming fraternities.
The management practices, processes and systems followed by Zydus Animal Health Limited rank amongst the best in the industry.
The Pharmaceutical Technology Centre of the Zydus group supports new product development of Zydus AHL. The Centre undertakes development of novel deliveries and conducts stability & toxicological studies as a part of product development.
Manned by nearly 400 scientists, the Pharmaceutical Technology Centre has an ultra-modern and a highly accredited world-class facility, equipped for development of all types of dosage forms.
In 2011, Zydus AHL expanded its presence in the global animal health business with the acquisition of Bremer Pharma GMBH, Germany. With a proven track record in poultry and livestock business, Bremer Pharma has an extensive network of distributors in more than 50 countries. The company has well established research facilities and infrastructure for manufacturing powders, tablets, liquid and parenterals in Warburg-Scherfede, Germany. The plant is compliant with the EC-GMP and EHS norms. It also has an extensive quality assurance system and a DIN ISO9001:2008 certification. Bremer Pharma has been in the Animal Health business since 1982.
With this acquisition, Zydus AHL gains strategic access to the key markets across Europe, South America, Asia and Africa.